{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:19:57Z","timestamp":1787861997315,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2021,9]]},"abstract":"\n Background and Purpose:<\/jats:title>\n Stroke survivors have an increased risk of depression and bone fractures. Selective serotonin reuptake inhibitors (SSRIs) have been associated with an increased risk of fractures in observational studies. Several randomized controlled trials (RCTs) reporting the effect of SSRIs on the risk of fractures in stroke survivors have been published recently but have not been subject to a meta-analysis. We aimed to determine the risk of fractures associated with the use of SSRIs, and the risk of falls, seizures, and recurrent strokes as possible mediators of fractures, in stroke survivors.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n We conducted a systematic review and meta-analysis of RCTs of SSRIs in stroke survivors according to a protocol registered in PROSPERO (CRD42020192632). Web of Science, EMBASE, PsycINFO, and Ovid Medline\/PubMed bibliographic databases, clinical trial registers, and grey literature sources were searched. RCTs of SSRIs versus placebo or no intervention that report the risk of fractures in adult survivors of hemorrhagic or ischemic stroke were included. Two reviewers independently screened search results and extracted data. Meta-analyses were conducted for each outcome using the Mantel-Haenszel random-effects models.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The searches yielded 683 records, of which 4 RCTs of 6 months duration with a total of 6549 participants were included in the meta-analysis: 3 studies of fluoxetine and 1 study of citalopram. Treatment with an SSRI for 6 months increased the risk of fractures with a risk ratio of 2.36 (95% CI, 1.64\u20133.39) compared with placebo. The risk of falls, seizures, and recurrent stroke was not statistically significantly increased. Only studies of fluoxetine and citalopram were available for inclusion in the review, and hence the generalizability of the findings to other SSRIs is uncertain.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Based on available RCTs of fluoxetine and citalopram, SSRIs used for 6 months doubled the risk of fractures in stroke survivors.<\/jats:p>\n <\/jats:sec>\n \n Registration:<\/jats:title>\n \n URL:\n https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:ext-link>\n ; Unique identifier: CRD42020192632.\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1161\/strokeaha.120.032973","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T09:00:18Z","timestamp":1624611618000},"page":"2802-2808","source":"Crossref","is-referenced-by-count":15,"title":["Risk of Fractures in Stroke Patients Treated With a Selective Serotonin Reuptake Inhibitor: A Systematic Review and Meta-Analysis"],"prefix":"10.1161","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0639-0823","authenticated-orcid":true,"given":"Joshua S.","family":"Jones","sequence":"first","affiliation":[{"name":"Medical School, Faculty of Health and Medical Sciences (J.S.J.), The University of Western Australia, Perth, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2624-572X","authenticated-orcid":true,"given":"Rina","family":"Kimata","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Curtin University, Perth, Western Australia, Australia (R.K.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8689-6199","authenticated-orcid":true,"given":"Osvaldo P.","family":"Almeida","sequence":"additional","affiliation":[{"name":"Medical School (O.P.A.), The University of Western Australia, Perth, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-7328","authenticated-orcid":true,"given":"Graeme J.","family":"Hankey","sequence":"additional","affiliation":[{"name":"Medical School, Faculty of Health and Medical Sciences (G.J.H.), The University of Western Australia, Perth, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"crossref","first-page":"e19431","DOI":"10.1371\/journal.pone.0019431","article-title":"Effect of stroke on fall rate, location and predictors: a prospective comparison of older adults with and without stroke.","volume":"6","author":"Simpson LA","year":"2011","unstructured":"Simpson, LA, Miller, WC, Eng, JJ. Effect of stroke on fall rate, location and predictors: a prospective comparison of older adults with and without stroke. PLoS One. 2011;6:e19431. doi: 10.1371\/journal.pone.0019431","journal-title":"PLoS One"},{"key":"e_1_3_6_3_2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/hs0202.102375","article-title":"Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke.","volume":"33","author":"J\u00f8rgensen L","year":"2002","unstructured":"J\u00f8rgensen, L, Engstad, T, Jacobsen, BK. Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke. Stroke. 2002;33:542\u2013547. doi: 10.1161\/hs0202.102375","journal-title":"Stroke"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/strokeaha.109.554055"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003457"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/hs0302.103621"},{"key":"e_1_3_6_7_2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00198-018-4420-1","article-title":"Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies.","volume":"29","author":"Wu Q","year":"2018","unstructured":"Wu, Q, Liu, B, Tonmoy, S. Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies. Osteoporos Int. 2018;29:1303\u20131312. doi: 10.1007\/s00198-018-4420-1","journal-title":"Osteoporos Int"},{"key":"e_1_3_6_8_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/jgs.12209","article-title":"Depressive symptomatology as a risk factor for falls in older people: systematic review and meta-analysis.","volume":"61","author":"Kvelde T","year":"2013","unstructured":"Kvelde, T, McVeigh, C, Toson, B, Greenaway, M, Lord, SR, Delbaere, K, Close, JC. Depressive symptomatology as a risk factor for falls in older people: systematic review and meta-analysis. J Am Geriatr Soc. 2013;61:694\u2013706.","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_6_9_2","first-page":"371.e311","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics.","volume":"19","author":"Seppala LJ","year":"2018","unstructured":"Seppala, LJ. Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics. J Am Med Dir Assoc. 2018;19:371.e311\u2013371.e317.","journal-title":"J Am Med Dir Assoc"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4551"},{"key":"e_1_3_6_11_2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/gps.4974","article-title":"Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: a systematic review and meta-analysis.","volume":"33","author":"Khanassov V","year":"2018","unstructured":"Khanassov, V, Hu, J, Reeves, D, van Marwijk, H. Selective serotonin reuptake inhibitor and selective serotonin and norepinephrine reuptake inhibitor use and risk of fractures in adults: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2018;33:1688\u20131708.","journal-title":"Int J Geriatr Psychiatry"},{"key":"e_1_3_6_12_2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamapsychiatry.2018.3679","article-title":"Association between antidepressant drug use and hip fracture in older people before and after treatment initiation.","volume":"76","author":"Br\u00e4nnstr\u00f6m J","year":"2019","unstructured":"Br\u00e4nnstr\u00f6m, J, L\u00f6vheim, H, Gustafson, Y, Nordstr\u00f6m, P. Association between antidepressant drug use and hip fracture in older people before and after treatment initiation. JAMA Psychiatry. 2019;76:172\u2013179. doi: 10.1001\/jamapsychiatry.2018.3679","journal-title":"JAMA Psychiatry"},{"key":"e_1_3_6_13_2","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jgs.15966","article-title":"Adverse effects of pharmacologic treatments of major depression in older adults.","volume":"67","author":"Sobieraj DM","year":"2019","unstructured":"Sobieraj, DM, Martinez, BK, Hernandez, AV, Coleman, CI, Ross, JS, Berg, KM, Steffens, DC, Baker, WL. Adverse effects of pharmacologic treatments of major depression in older adults. J Am Geriatr Soc. 2019;67:1571\u20131581. doi: 10.1111\/jgs.15966","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_6_14_2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","article-title":"Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis.","volume":"27","author":"Eom CS","year":"2012","unstructured":"Eom, CS, Lee, HK, Ye, S, Park, SM, Cho, KH. Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. J Bone Miner Res. 2012;27:1186\u20131195.","journal-title":"J Bone Miner Res"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijs.12357"},{"key":"e_1_3_6_16_2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1017\/S0033291718002003","article-title":"Prevalence of pre-stroke depression and its association with post-stroke depression: a systematic review and meta-analysis.","volume":"49","author":"Taylor-Rowan M","year":"2019","unstructured":"Taylor-Rowan, M, Momoh, O, Ayerbe, L, Evans, JJ, Stott, DJ, Quinn, TJ. Prevalence of pre-stroke depression and its association with post-stroke depression: a systematic review and meta-analysis. Psychol Med. 2019;49:685\u2013696. doi: 10.1017\/S0033291718002003","journal-title":"Psychol Med"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32802-7"},{"key":"e_1_3_6_18_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0140-6736(18)32823-X","article-title":"Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.","volume":"393","author":"FOCUS Trial Collaboration","year":"2019","unstructured":"FOCUS Trial Collaboration. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial. Lancet. 2019;393:265\u2013274. doi: 10.1016\/S0140-6736(18)32823-X","journal-title":"Lancet"},{"key":"e_1_3_6_19_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(20)30219-2","article-title":"Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.","volume":"19","author":"EFFECTS Trial Collaboration","year":"2020","unstructured":"EFFECTS Trial Collaboration. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:661\u2013669. doi: 10.1016\/S1474-4422(20)30219-2","journal-title":"Lancet Neurol"},{"key":"e_1_3_6_20_2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1474-4422(20)30207-6","article-title":"Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.","volume":"19","author":"AFFINITY Trial Collaboration","year":"2020","unstructured":"AFFINITY Trial Collaboration. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2020;19:651\u2013660. doi: 10.1016\/S1474-4422(20)30207-6","journal-title":"Lancet Neurol"},{"key":"e_1_3_6_21_2","first-page":"CRD42020192632","article-title":"The effect of selective serotonin reuptake inhibitors (SSRI) on the risk of fractures in adults with stroke: protocol for a systematic review and meta-analysis of RCTs.","author":"Jones J","year":"2020","unstructured":"Jones, J, Kimata, R, Hankey, G. The effect of selective serotonin reuptake inhibitors (SSRI) on the risk of fractures in adults with stroke: protocol for a systematic review and meta-analysis of RCTs. PROSPERO. 2020:CRD42020192632","journal-title":"PROSPERO"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898"},{"key":"e_1_3_6_24_2","volume-title":"Review manager (RevMan) [computer program]. Version 5.4","year":"2020","unstructured":"Review manager (RevMan) [computer program]. Version 5.4, The Cochrane Collaboration, 2020."},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.020067"},{"key":"e_1_3_6_26_2","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/jgs.16404","article-title":"Multinational investigation of fracture risk with antidepressant use by class, drug, and indication.","volume":"68","author":"Tamblyn R","year":"2020","unstructured":"Tamblyn, R, Bates, DW, Buckeridge, DL, Dixon, WG, Girard, N, Haas, JS, Habib, B, Iqbal, U, Li, J, Sheppard, T. Multinational investigation of fracture risk with antidepressant use by class, drug, and indication. J Am Geriatr Soc. 2020;68:1494\u20131503. doi: 10.1111\/jgs.16404","journal-title":"J Am Geriatr Soc"},{"key":"e_1_3_6_27_2","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00228-020-02893-1","article-title":"Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis.","volume":"76","author":"Kumar M","year":"2020","unstructured":"Kumar, M, Bajpai, R, Shaik, AR, Srivastava, S, Vohora, D. Alliance between selective serotonin reuptake inhibitors and fracture risk: an updated systematic review and meta-analysis. Eur J Clin Pharmacol. 2020;76:1373\u20131392. doi: 10.1007\/s00228-020-02893-1","journal-title":"Eur J Clin Pharmacol"},{"key":"e_1_3_6_28_2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.apmr.2015.08.431","article-title":"Increased lower limb spasticity but not strength or function following a single-dose serotonin reuptake inhibitor in chronic stroke.","volume":"96","author":"Gourab K","year":"2015","unstructured":"Gourab, K, Schmit, BD, Hornby, TG. Increased lower limb spasticity but not strength or function following a single-dose serotonin reuptake inhibitor in chronic stroke. Arch Phys Med Rehabil. 2015;96:2112\u20132119. doi: 10.1016\/j.apmr.2015.08.431","journal-title":"Arch Phys Med Rehabil"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.82"},{"key":"e_1_3_6_30_2","first-page":"Doc15","article-title":"Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients.","volume":"12","author":"Kostev K","year":"2014","unstructured":"Kostev, K, Rex, J, Eith, T, Heilmaier, C. Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients. Ger Med Sci. 2014;12:Doc15","journal-title":"Ger Med Sci"},{"key":"e_1_3_6_31_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","article-title":"Antidepressant medications and osteoporosis.","volume":"51","author":"Rizzoli R","year":"2012","unstructured":"Rizzoli, R, Cooper, C, Reginster, JY, Abrahamsen, B, Adachi, JD, Brandi, ML, Bruy\u00e8re, O, Compston, J, Ducy, P, Ferrari, S, et al. Antidepressant medications and osteoporosis. Bone. 2012;51:606\u2013613. doi: 10.1016\/j.bone.2012.05.018","journal-title":"Bone"},{"key":"e_1_3_6_32_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s40266-015-0323-4","article-title":"Effects of depression and serotonergic antidepressants on bone: mechanisms and implications for the treatment of depression.","volume":"33","author":"Fernandes BS","year":"2016","unstructured":"Fernandes, BS, Hodge, JM, Pasco, JA, Berk, M, Williams, LJ. Effects of depression and serotonergic antidepressants on bone: mechanisms and implications for the treatment of depression. Drugs Aging. 2016;33:21\u201325. doi: 10.1007\/s40266-015-0323-4","journal-title":"Drugs Aging"},{"key":"e_1_3_6_33_2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","article-title":"Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.","volume":"167","author":"Haney EM","year":"2007","unstructured":"Haney, EM, Chan, BK, Diem, SJ, Ensrud, KE, Cauley, JA, Barrett-Connor, E, Orwoll, E, Bliziotes, MM; Osteoporotic Fractures in Men Study Group. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007;167:1246\u20131251. doi: 10.1001\/archinte.167.12.1246","journal-title":"Arch Intern Med"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-020-05535-5"},{"key":"e_1_3_6_35_2","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00198-014-3005-x","article-title":"Risk of osteoporotic fractures following stroke in older persons.","volume":"26","author":"Benzinger P","year":"2015","unstructured":"Benzinger, P, Rapp, K, K\u00f6nig, HH, Bleibler, F, Globas, C, Beyersmann, J, Jaensch, A, Becker, C, B\u00fcchele, G. Risk of osteoporotic fractures following stroke in older persons. Osteoporos Int. 2015;26:1341\u20131349. doi: 10.1007\/s00198-014-3005-x","journal-title":"Osteoporos Int"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/STROKEAHA.120.032973","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T15:26:21Z","timestamp":1647703581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/STROKEAHA.120.032973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["10.1161\/STROKEAHA.120.032973"],"URL":"https:\/\/doi.org\/10.1161\/strokeaha.120.032973","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}